Search
for

    Sort by

    Research 61–90 of 1000+

    1. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    2. Analytical methods of dutasteride: An overview Annals of phytomedicine · 2023
    3. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    4. 5α‐Reductase Inhibitors Andrology · 1997 · 17 citations
    5. New Selenoderivatives as Antitumoral Agents InTech eBooks · 2011
    6. Long-Term Experience With 5-alpha-Reductase Inhibitors. PubMed · 2003 · 6 citations
    7. 5alpha-reductase: history and clinical importance. PubMed · 2004 · 62 citations
    8. Going Beyond Hair: Seven Simple Actions We Can Take to Help Prevent Major Illness in Our Hair Transplant Patients Hair transplant forum international · 2014
    9. Prostatakarzinom Der Urologe · 2011
    10. The clinical applications of five-alpha reductase inhibitors. Canadian Journal of Urology · 2021 · 2 citations
    11. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    12. Dutasteride Drugs · 2008 · 45 citations
    13. Finasterid in der Behandlung der benignen Prostatahyperplasie Der Urologe · 2012 · 1 citations
    14. EFFECTS OF FESOTERODINE, A NOVEL ANTIMUSCARINIC, ALONE AND IN COMBINATION WITH AN α-RECEPTOR BLOCKER, DOXAZOSIN, ON BLADDER FUNCTION IN OBSTRUCTED RATS The Journal of Urology · 2009 · 1 citations
    15. The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review Consilium Medicum · 2025
    16. Clarification Dermatologic Surgery · 2000
    17. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    18. 5α-Reductase: History and Clinical Importance PubMed Central · 2004 · 20 citations
    19. Comparative Outcomes of Cutaneous Vesicostomy Versus Cystoscopic Valve Ablation in the Initial Management of Posterior Urethral Valves ARC Journal of Urology · 2025
    20. Les Visiteurs des malades Nature Clinical Practice Urology · 2011
    21. The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients The Journal of Urology · 2003 · 90 citations
    22. Natural bioactive compounds as potential sources for alleviation and treatment of androgenetic alopecia: A research advance eFood · 2024
    23. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006 · 52 citations
    24. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    25. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    26. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    27. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    28. Recent advances in treatment for Benign Prostatic Hyperplasia F1000Research · 2015 · 12 citations
    29. Endocrine treatment of benign prostatichypertrophy: Current concepts Urology · 1991 · 11 citations
    30. Telogen effluvium on the unilateral flank with testicular tumor in a dog Jui rinsho hifuka · 2019